China punishes pharmaceutical supplier for abuse of dominance

China’s competition watchdog has ordered one of the country’s largest suppliers of active pharmaceutical ingredients to pay over €1.4 million for imposing excessive prices on drug manufacturers from 2014 to 2017.


Get unlimited access to all Global Competition Review content